1. Home
  2. |Insights
  3. |CMS Issues RADV Methodology for Comment

CMS Issues RADV Methodology for Comment

Client Alert | less than 1 min read | 12.22.10

CMS has issued for review and comment its draft proposed risk adjustment data validation (RADV) extrapolation/payment error calculation methodology applicable to Medicare Advantage organizations. Click here for a copy of the draft. Comments are due January 21, 2011. We will provide an analysis of the proposed methodology in the near future. In the meantime, please contact Christine Rinn if you have any questions.

Insights

Client Alert | 4 min read | 01.07.26

FDA Request for Information Signals New Path for VC Firms and their Portfolio Companies in Federal Contracting

On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026....